Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission

The Lancet Infectious Diseases

Volumn 18, Issue 8, 2018, Pages e217-e227

  Hui, David S ^a   Azhar, Esam I ^b   Kim, Yae Jean ^c   Memish, Ziad A ^d,e,f   Oh, Myoung don ^g   Zumla, Alimuddin ^h,i  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d ALFAISAL UNIVERSITY   (Saudi Arabia)

^e Ministry of Health   (Saudi Arabia)

^f EMORY UNIVERSITY   (United States)

^g Seoul National University College of Medicine   (South Korea)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁱ UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AWARENESS; CLINICAL FEATURE; DEATH; DISEASE SEVERITY; DISEASE TRANSMISSION; GLOBAL HEALTH; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HOUSEHOLD; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; MIDDLE EAST RESPIRATORY SYNDROME; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; TRAVEL; VIRAL CONTAMINATION; VIRUS LOAD; VIRUS TRANSMISSION; ANIMAL; CAMEL; CORONAVIRUS INFECTION; CROSS INFECTION; EPIDEMIC; FAMILY SIZE; ISOLATION AND PURIFICATION; MORTALITY; PATHOGENICITY; SAUDI ARABIA; ZOONOSIS;

ANIMALS; CAMELUS; CORONAVIRUS INFECTIONS; CROSS INFECTION; DISEASE OUTBREAKS; DISEASE TRANSMISSION, INFECTIOUS; FAMILY CHARACTERISTICS; GLOBAL HEALTH; HUMANS; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; RISK FACTORS; SAUDI ARABIA; ZOONOSES;

EID: 85043521307     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(18)30127-0     Document Type: Review

References (79)

1. Peiris, JS, Yuen, KY, Osterhaus, AD, Stöhr, K, The severe acute respiratory syndrome. N Engl J Med 349 (2003), 2431–2441.
2. WHO. Severe acute respiratory syndrome. http://www.who.int/topics/sars/en/ (accessed March 28, 2018).
3. Hui, DS, Memish, ZA, Zumla, A, Severe acute respiratory syndrome vs the Middle East respiratory syndrome. Curr Opin Pulm Med 20 (2014), 233–241.
4. WHO. Middle East respiratory syndrome coronavirus (MERS-CoV). http://www.who.int/emergencies/mers-cov/en/ (accessed Jan 16, 2018).
5. Zumla, A, Hui, DS, Perlman, S, Middle East respiratory syndrome. Lancet 386 (2015), 995–1007.
6. Lee, JY, Kim, YJ, Chung, EH, et al. The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea, 2015. BMC Infect Dis, 17, 2017, 498.
7. Majumder, MS, Brownstein, JS, Finkelstein, SN, Larson, RC, Bourouiba, L, Nosocomial amplification of MERS-coronavirus in South Korea, 2015. Trans R Soc Trop Med Hyg 111 (2017), 261–269.
8. Korea Centers for Disease Control and Prevention. Middle East respiratory syndrome coronavirus outbreak in the Republic of Korea, 2015. Osong Public Health Res Perspect 6 (2015), 269–327.
9. WHO. WHO statement on the ninth meeting of the IHR Emergency Committee regarding MERS-CoV. http://www.who.int/mediacentre/news/statements/2015/ihr-ec-mers/en/, June 17, 2015 (accessed Oct 15, 2017).
10. WHO. List of blueprint priority diseases. http://www.who.int/blueprint/priority-diseases/en/ (accessed March 28, 2018).
11. Zaki, AM, van Boheemen, S, Bestebroer, TM, et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367 (2012), 1814–1820.
12. Arabi, YM, Balkhy, HH, Hayden, FG, et al. Middle East respiratory syndrome. N Engl J Med 376 (2017), 584–594.
13. Saudi Arabia Ministry of Health. MERS-CoV daily update. https://www.moh.gov.sa/en/CCC/PressReleases/Pages/statistics-2018-01-14-001.aspx (accessed March 19, 2018).
14. Memish, ZA, Mishra, N, Olival, KJ, et al. Middle East respiratory syndrome coronavirus in bats, Saudi Arabia. Emerg Infect Dis 19 (2013), 1819–1823.
15. Reusken, CB, Farag, EA, Jonges, M, et al. Middle East respiratory syndrome coronavirus (MERS-CoV) RNA and neutralising antibodies in milk collected according to local customs from dromedary camels, Qatar, April 2014. Euro Surveill, 19, 2014, 20829.
16. Ali, MA, Shehata, MM, Gomaa, MR, et al. Systematic, active surveillance for Middle East respiratory syndrome coronavirus in camels in Egypt. Emerg Microbes Infect, 6, 2017, e1.
17. van Doremalen, N, Bushmaker, T, Munster, VJ, Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions. Euro Surveill, 18, 2013, 20590.
18. Sikkema, RS, Farag, EA, Himatt, S, et al. Risk factors for primary Middle East respiratory syndrome coronavirus infection in camel workers in Qatar during 2013–2014: a case-control study. J Infect Dis 215 (2017), 1702–1705.
19. Alraddadi, BM, Watson, JT, Almarashi, A, et al. Risk factors for primary Middle East respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014. Emerg Infect Dis 22 (2016), 49–55.
20. Arwady, MA, Alraddadi, B, Basler, C, et al. Middle East respiratory syndrome coronavirus transmission in extended family, Saudi Arabia, 2014. Emerg Infect Dis 22 (2016), 1395–1402.
21. Müller, MA, Meyer, B, Corman, VM, et al. Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study. Lancet Infect Dis 15 (2015), 559–564.
22. Azhar, EI, El-Kafrawy, SA, Farraj, SA, et al. Evidence for camel-to-human transmission of MERS coronavirus. N Engl J Med 370 (2014), 2499–2505.
23. Memish, ZA, Cotten, M, Meyer, B, et al. Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013. Emerg Infect Dis 20 (2014), 1012–1015.
24. Al Hammadi, ZM, Chu, DK, Eltahir, YM, et al. Asymptomatic MERS-CoV infection in humans possibly linked to infected dromedaries imported from Oman to United Arab Emirates, May 2015. Emerg Infect Dis 21 (2015), 2197–2200.
25. Kasem, S, Qasim, I, Al-Hufofi, A, et al. Cross-sectional study of MERS-CoV-specific RNA and antibodies in animals that have had contact with MERS patients in Saudi Arabia. J Infect Public Health, 2017 published online Oct 6. DOI:10.1016/j.jiph.2017.09.022.
26. Hemida, MG, Al-Naeem, A, Perera, RA, Chin, AW, Poon, LL, Peiris, M, Lack of Middle East respiratory syndrome coronavirus transmission from infected camels. Emerg Infect Dis 21 (2015), 699–701.
27. Dudas, G, Carvalho, LM, Rambaut, A, Bedford, T, MERS-CoV spillover at the camel-human interface. ELife, 2018 published online Jan 16. DOI:10.7554/eLife.31257.
28. Al-Abdallat, MM, Payne, DC, Alqasrawi, S, et al. Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description. Clin Infect Dis 59 (2014), 1225–1233.
29. Assiri, A, McGeer, A, Perl, TM, et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med 369 (2013), 407–416.
30. Memish, ZA, Zumla, AI, Assiri, A, Middle East respiratory syndrome coronavirus infections in health care workers. N Engl J Med 369 (2013), 884–886.
31. Memish, ZA, Al-Tawfiq, JA, Assiri, A, Hospital-associated Middle East respiratory syndrome coronavirus infections. N Engl J Med 369 (2013), 1761–1762.
32. Memish, ZA, Zumla, AI, Al-Hakeem, RF, et al. Family cluster of Middle East respiratory syndrome coronavirus infections. N Engl J Med 368 (2013), 2487–2494.
33. Garbati, MA, Fagbo, SF, Fang, VJ, et al. A comparative study of clinical presentation and risk factors for adverse outcome in patients hospitalised with acute respiratory disease due to MERS coronavirus or other causes. PLoS One, 11, 2016, e0165978.
34. Mohd, HA, Memish, ZA, Alfaraj, SH, et al. Predictors of MERS-CoV infection: a large case control study of patients presenting with ILI at a MERS-CoV referral hospital in Saudi Arabia. Travel Med Infect Dis 14 (2016), 464–470.
35. Oh, MD, Park, WB, Choe, PG, et al. Viral load kinetics of MERS coronavirus infection. N Engl J Med 375 (2016), 1303–1305.
36. Memish, ZA, Assiri, AM, Al-Tawfiq, JA, Middle East respiratory syndrome coronavirus (MERS-CoV) viral shedding in the respiratory tract: an observational analysis with infection control implications. Int J Infect Dis 29 (2014), 307–308.
37. Zhou, J, Li, C, Zhao, G, et al. Human intestinal tract serves an alternative infection route for Middle East respiratory syndrome coronavirus. Sci Adv, 3, 2017, eaao4966.
38. Ahmed, AE, The predictors of 3- and 30-day mortality in 660 MERS-CoV patients. BMC Infect Dis, 17, 2017, 615.
39. Rivers, CM, Majumder, MS, Lofgren, ET, Risks of death and severe disease in patients with Middle East respiratory syndrome coronavirus, 2012–2015. Am J Epidemiol 184 (2016), 460–464.
40. Yang, YM, Hsu, CY, Lai, CC, et al. Impact of comorbidity on fatality rate of patients with Middle East respiratory syndrome. Sci Rep, 7, 2017, 11307.
41. Hong, KH, Choi, JP, Hong, SH, et al. Predictors of mortality in Middle East respiratory syndrome (MERS). Thorax, 2017 published online July 19. DOI:10.1136/thoraxjnl-2016-209313.
42. Seys, LJ, Widagdo, W, Verhamme, FM, et al. DPP4, the MERS coronavirus receptor, is upregulated in lungs of smokers and COPD patients. Clin Infect Dis 66 (2018), 45–53.
43. Lee, JY, Kim, YJ, Chung, EH, et al. The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea, 2015. BMC Infect Dis, 17, 2017, 498.
44. Al-Gethamy, M, Corman, VM, Hussain, R, et al. A case of long-term excretion and subclinical infection with Middle East respiratory syndrome coronavirus in a healthcare worker. Clin Infect Dis 60 (2015), 973–974.
45. Drosten, C, Meyer, B, Müller, MA, et al. Transmission of MERS-coronavirus in household contacts. N Engl J Med 371 (2014), 828–835.
46. Omrani, AS, Matin, MA, Haddad, Q, et al. A family cluster of Middle East respiratory syndrome coronavirus infections related to a likely unrecognized asymptomatic or mild case. Int J Infect Dis 17 (2013), e668–e672.
47. Nam, HS, Park, JW, Ki, M, et al. High fatality rates and associated factors in two hospital outbreaks of MERS in Daejeon, the Republic of Korea. Int J Infect Dis 58 (2017), 37–42.
48. Oboho, IK, Tomczyk, SM, Al-Asmari, AM, et al. 2014 MERS-CoV outbreak in Jeddah—a link to health care facilities. N Engl J Med 372 (2015), 846–854.
49. Alenazi, TH, Al Arbash, H, El-Saed, A, et al. Identified transmission dynamics of Middle East respiratory syndrome coronavirus infection during an outbreak: implications of an overcrowded emergency department. Clin Infect Dis 65 (2017), 675–679.
50. Al Hosani, FI, Pringle, K, Al Mulla, M, et al. Response to emergence of Middle East respiratory syndrome coronavirus, Abu Dhabi, United Arab Emirates, 2013–2014. Emerg Infect Dis 22 (2016), 1162–1168.
51. Alfaraj, SH, Al-Tawfiq, JA, Altuwaijri, TA, et al. Middle East respiratory syndrome coronavirus transmission among health care workers: implication for infection control. Am J Infect Control, 2017 published online Sept 25. DOI:10.1016/j.ajic.2017.08.010.
52. Kim, SW, Park, JW, Jung, HD, et al. Risk factors for transmission of Middle East respiratory syndrome coronavirus infection during the 2015 outbreak in South Korea. Clin Infect Dis 64 (2017), 551–557.
53. Bin, SY, Heo, JY, Song, MS, et al. Environmental contamination and viral shedding in MERS patients during MERS-CoV outbreak in South Korea. Clin Infect Dis 62 (2016), 755–760.
54. Kang, CK, Song, KH, Choe, PG, et al. Clinical and epidemiologic characteristics of spreaders of Middle East respiratory syndrome coronavirus during the 2015 outbreak in Korea. J Korean Med Sci 32 (2017), 744–749.
55. Kim, SH, Chang, SY, Sung, M, et al. Extensive viable Middle East respiratory syndrome (MERS) coronavirus contamination in air and surrounding environment in MERS isolation wards. Clin Infect Dis 63 (2016), 363–369.
56. Hunter, JC, Nguyen, D, Aden, B, et al. Transmission of Middle East respiratory syndrome coronavirus infections in healthcare settings, Abu Dhabi. Emerg Infect Dis 22 (2016), 647–656.
57. Cho, SY, Kang, J-M, Ha, YE, et al. MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study. Lancet 388 (2016), 994–1001.
58. WHO. WHO MERS-CoV global summary and assessment of risk. http://www.who.int/emergencies/mers-cov/risk-assessment-july-2017.pdf?ua=1, 21 July 2017 (accessed Nov 5, 2017).
59. Alraddadi, BM, Al-Salmi, HS, Jacobs-Slifka, K, et al. Risk factors for Middle East respiratory syndrome coronavirus infection among healthcare personnel. Emerg Infect Dis 22 (2016), 1915–1920.
60. Majumder, MS, Brownstein, JS, Finkelstein, SN, Larson, RC, Bourouiba, L, Nosocomial amplification of MERS-coronavirus in South Korea, 2015. Trans R Soc Trop Med Hyg 111 (2017), 261–269.
61. Choi, S, Jung, E, Choi, BY, Hur, YJ, Ki, M, High reproduction number of Middle East respiratory syndrome coronavirus in nosocomial outbreaks: mathematical modelling in Saudi Arabia and South Korea. J Hosp Infect, 2017 published online Sept 25. DOI:10.1016/j.jhin.2017.09.017.
62. Song, JY, Cheong, HJ, Choi, MJ, et al. Viral shedding and environmental cleaning in Middle East respiratory syndrome coronavirus infection. Infect Chemother 47 (2015), 252–255.
63. Corman, VM, Albarrak, AM, Omrani, AS, et al. Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection. Clin Infect Dis 62 (2016), 477–483.
64. Park, GE, Ko, JH, Peck, KR, et al. Control of an outbreak of Middle East respiratory syndrome in a tertiary hospital in Korea. Ann Intern Med 165 (2016), 87–93.
65. Moon, SY, Son, JS, Infectivity of an asymptomatic patient with Middle East respiratory syndrome coronavirus infection. Clin Infect Dis 64 (2017), 1457–1458.
66. WHO. Infection prevention and control during health care for probable or confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection Interim guidance. 2015, World Health Organization, Geneva http://www.who.int/csr/disease/coronavirus_infections/ipc-mers-cov/en/ (accessed Jan 17, 2018).
67. WHO. WHO guidelines on natural ventilation for infection control in health-care settings. 2009, World Health Organization, Geneva http://whqlibdoc.who.int/publications/2009/9789241547857_eng.pdf (accessed Nov 11, 2017).
68. WHO. Management of asymptomatic persons who are RTPCR positive for Middle East respiratory syndrome coronavirus (MERS-CoV). Interim Guidance. Updated Jan 3, 2018 http://apps.who.int/iris/bitstream/10665/180973/1/WHO_MERS_IPC_15.2_eng.pdf?ua=1&ua=1 (accessed Jan 16, 2018).
69. WHO. Middle East respiratory syndrome coronavirus (MERS-CoV). Fact sheet. Updated May 2017 http://www.who.int/mediacentre/factsheets/mers-cov/en/ (accessed Jan 16, 2018).
70. Chu, DK, Chan, SM, Perera, RA, et al. MERS-CoV in Arabian camels in Africa and Central Asia. Virus Evol, 3(suppl 1), 2017 vew036.045.
71. Miguel, E, Perera, RA, Baubekova, et al. Absence of Middle East respiratory syndrome coronavirus in camelids, Kazakhstan, 2015. Emerg Infect Dis 22 (2016), 555–557.
72. Tran, K, Cimon, K, Severn, M, Pessoa-Silva, CL, Conly, J, Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review. PLoS One, 7, 2012, e35797.
73. Al-Tawfiq, JA, Zumla, A, Memish, ZA, Coronaviruses: severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus in travelers. Curr Opin Infect Dis 27 (2014), 411–417.
74. Hui, DS, Perlman, S, Zumla, A, Spread of MERS to South Korea and China. Lancet Respir Med 3 (2015), 509–510.
75. Memish, ZA, Zumla, A, Alhakeem, RF, et al. Hajj: infectious disease surveillance and control. Lancet 383 (2014), 2073–2082.
76. Zumla, A, Rustomjee, R, Ntoumi, F, et al. Middle East respiratory syndrome—need for increased vigilance and watchful surveillance for MERS-CoV in sub-Saharan Africa. Int J Infect Dis 37 (2015), 77–79.
77. Zumla, A, Hui, DS, Infection control and MERS-CoV in health-care workers. Lancet 383 (2014), 1869–1871.
78. Zumla, A, Chan, JF, Azhar, EI, Hui, DS, Yuen, KY, Coronaviruses—drug discovery and therapeutic options. Nat Rev Drug Discov 15 (2016), 327–347.
79. Hui, DS, Zumla, A, Advancing priority research on the Middle East respiratory syndrome coronavirus. J Infect Dis 209 (2014), 173–176.